Hussman Strategic Advisors Inc. Makes New $1.22 Million Investment in Pediatrix Medical Group, Inc. (NYSE:MD)

Hussman Strategic Advisors Inc. purchased a new position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 84,000 shares of the company's stock, valued at approximately $1,217,000. Hussman Strategic Advisors Inc. owned 0.10% of Pediatrix Medical Group at the end of the most recent quarter.

Other institutional investors have also added to or reduced their stakes in the company. California State Teachers Retirement System raised its position in shares of Pediatrix Medical Group by 0.9% during the 4th quarter. California State Teachers Retirement System now owns 80,327 shares of the company's stock valued at $1,054,000 after purchasing an additional 752 shares during the period. SummerHaven Investment Management LLC raised its position in shares of Pediatrix Medical Group by 0.9% during the 1st quarter. SummerHaven Investment Management LLC now owns 112,327 shares of the company's stock valued at $1,628,000 after buying an additional 1,028 shares in the last quarter. Nomura Asset Management Co. Ltd. grew its stake in Pediatrix Medical Group by 95.3% in the 4th quarter. Nomura Asset Management Co. Ltd. now owns 2,500 shares of the company's stock worth $33,000 after acquiring an additional 1,220 shares in the last quarter. GAMMA Investing LLC grew its stake in Pediatrix Medical Group by 219.5% in the 1st quarter. GAMMA Investing LLC now owns 2,569 shares of the company's stock worth $37,000 after acquiring an additional 1,765 shares in the last quarter. Finally, New York State Teachers Retirement System boosted its stake in shares of Pediatrix Medical Group by 1.9% during the first quarter. New York State Teachers Retirement System now owns 133,313 shares of the company's stock valued at $1,932,000 after purchasing an additional 2,527 shares in the last quarter. 97.71% of the stock is currently owned by institutional investors.

Pediatrix Medical Group Stock Performance

MD traded down $0.27 on Friday, reaching $12.57. The stock had a trading volume of 543,188 shares, compared to its average volume of 720,427. Pediatrix Medical Group, Inc. has a 12-month low of $7.40 and a 12-month high of $17.67. The company has a current ratio of 1.81, a quick ratio of 1.81 and a debt-to-equity ratio of 0.75. The business's 50-day moving average price is $13.83 and its two-hundred day moving average price is $13.87. The company has a market cap of $1.08 billion, a P/E ratio of -12.45, a price-to-earnings-growth ratio of 0.85 and a beta of 1.25.

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating analysts' consensus estimates of $0.25 by $0.08. Pediatrix Medical Group had a negative net margin of 4.17% and a positive return on equity of 17.43%. The company had revenue of $458.36 million during the quarter, compared to analysts' expectations of $451.44 million. During the same quarter in the previous year, the company earned $0.20 earnings per share. The firm's revenue for the quarter was down 7.4% on a year-over-year basis. Sell-side analysts forecast that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Analyst Ratings Changes

MD has been the subject of a number of analyst reports. UBS Group decreased their target price on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a "neutral" rating for the company in a research report on Monday, May 12th. Macquarie increased their target price on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the company an "outperform" rating in a research report on Thursday, May 8th. Finally, Truist Financial decreased their target price on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a "hold" rating for the company in a research report on Friday, April 11th. Four investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Hold" and an average target price of $16.67.

Pediatrix Medical Group Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.